Abstract: The present invention relates to a gene delivery stent using titanium oxide thin film coating and a method for fabricating the gene delivery stent. The gene delivery stent according to the present invention may be loaded with a drug having anti-inflammatory and anti-thrombotic effects and simultaneously deliver a gene capable of inhibiting proliferation of vascular smooth muscle cells. Accordingly, late thrombosis and metal allergy may be reduced, and vascular restenosis in the stent region may be prevented, thereby making it possible to increase treatment effects of the bare metal stent.

Abstract: The present invention relates to a gene delivery stent using titanium oxide thin film coating and a method for fabricating the gene delivery stent. The gene delivery stent according to the present invention may be loaded with a drug having anti-inflammatory and anti-thrombotic effects and simultaneously deliver a gene capable of inhibiting proliferation of vascular smooth muscle cells. Accordingly, late thrombosis and metal allergy may be reduced, and vascular restenosis in the stent region may be prevented, thereby making it possible to increase treatment effects of the bare metal stent.

Abstract: The present invention relates to a gene delivery stent using titanium oxide thin film coating and a method for fabricating the gene delivery stent. The gene delivery stent according to the present invention may be loaded with a drug having anti-inflammatory and anti-thrombotic effects and simultaneously deliver a gene capable of inhibiting proliferation of vascular smooth muscle cells. Accordingly, late thrombosis and metal allergy may be reduced, and vascular restenosis in the stent region may be prevented, thereby making it possible to increase treatment effects of the bare metal stent.

Abstract: A method for manufacturing a drug-releasing stent is provided. The method includes providing a titanium precursor, a carrier gas and a reactant gas in a plasma vacuum chamber, and generating a plasma for 1 to 6 hours to form a titanium oxide thin film on the surface of a stent. The method further includes providing steam or oxygen and hydrogen in the plasma vacuum chamber and generating a low-temperature plasma for 10 minutes to 2 hours to modify the surface of the titanium oxide thin film. The method further includes reacting the titanium oxide thin film of the stent with a drug in an acidic solution and under an inert gas atmosphere at room temperature to 100° C. for 30 minutes to 4 hours to attach the drug.

Abstract: The present invention relates to a gene delivery stent using titanium oxide thin film coating and a method for fabricating the gene delivery stent. The gene delivery stent according to the present invention may be loaded with a drug having anti-inflammatory and anti-thrombotic effects and simultaneously deliver a gene capable of inhibiting proliferation of vascular smooth muscle cells. Accordingly, late thrombosis and metal allergy may be reduced, and vascular restenosis in the stent region may be prevented, thereby making it possible to increase treatment effects of the bare metal stent.

Abstract: The present invention relates to a method for recovering an organic-inorganic element-doped metal oxide from a hydrolysable metal compound, accompanied with contaminated water treatment. The present invention comprises steps of: a) adding a hydrolysable metal compound as a coagulant to a contaminated water to form a separable floc between the hydrolysable metal compound and contaminants present in contaminated water; b) separating the separable floc and the pre-treated water after flocculation treatment; and c) calcinating the separated floc over 500° C. to produce an organic-inorganic element-doped metal oxide. More preferably, the present invention further comprises subjecting the pre-treated water of the step b) to a microwave treatment to cause a photocatalytic degradation of an organic contaminant that remains in the pre-treated water, with the assistance of the remaining hydrolysable metal compound.

Abstract: Disclosed is a method for manufacturing a drug-releasing stent, including: coating a titanium dioxide or nitrogen-doped titanium dioxide thin film on a metal stent; and attaching a drug on the surface of the titanium oxide thin film. More specifically, the method for manufacturing a drug-releasing stent includes: coating a titanium dioxide or nitrogen-doped titanium dioxide thin film on a metal stent, which can be inserted into the blood vessel, by plasma enhanced chemical vapor deposition (PECVD); modifying the surface of the titanium oxide thin film with hydroxyl groups by low-temperature plasma; and chemically attaching a drug such as an antithrombotic drug or a neointimal hyperplasia inhibitor, so that the drug may be released in the blood vessel in a sustained manner.

Abstract: The present invention relates to a method for recovering an organic-inorganic element-doped metal oxide from a hydrolysable metal compound, accompanied with contaminated water treatment. The present invention comprises steps of: a) adding a hydrolysable metal compound as a coagulant to a contaminated water to form a separable floc between the hydrolysable metal compound and contaminants present in contaminated water; b) separating the separable floc and the pre-treated water after flocculation treatment; and c) calcinating the separated floc over 500° C. to produce an organic-inorganic element-doped metal oxide. More preferably, the present invention further comprises subjecting the pre-treated water of the step b) to a microwave treatment to cause a photocatalytic degradation of an organic contaminant that remains in the pre-treated water, with the assistance of the remaining hydrolysable metal compound.